U.S. Medical Device Giant Edwards Lifesciences Acquired Vectorious for $497 Million, After a 52 Percent Stake Deal in 2023. Vectorious' Tiny Battery-free Sensor, Still in Clinical Trials, Monitors Heart Pressure via an App. The Tel Aviv Team Will Become Edwards' R&D Center for Implanted Sensors.